Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Will Trial Results for Lilly and Biogen Alzheimer’s Drugs be Hard to Forget?
Will Trial Results for Lilly and Biogen Alzheimer’s Drugs be Hard to Forget?
Will Trial Results for Lilly and Biogen Alzheimer’s Drugs be Hard to Forget?
Submitted by
admin
on July 20, 2015 - 11:01pm
Source:
WSJ Pharmalot
News Tags:
Eli Lilly
Biogen
clinical trials
Alzheimer's disease
aducanumab
solanezumab
Headline:
Will Trial Results for Lilly and Biogen Alzheimer’s Drugs be Hard to Forget?
Do Not Allow Advertisers to Use My Personal information
